QI |
Quality Improvement |
NBS |
Newborn Screening |
RUSP |
Recommended Uniform Screening Panel |
X-ALD |
X-linked adrenal leukodystrophy |
PD |
Pompe disease |
MPS I |
Mucopolysaccharidosis type I |
GAA |
-glucosidase |
IDUA |
-L-iduronidase |
PPV |
Positive Predictive Value |
GAGs |
Glycosaminoglycans |
CLIR |
Collaborative Laboratory Integrated Reports |
MoM |
Multiples of the Median |
QC |
Quality Control |
PT |
Proficiency Testing |
DMF |
Digital Microfluidics |
MS/MS |
Tandem Mass Spectrometry |
LD |
Lysosomal Disorders |
NSQAP |
Newborn Screening Quality Assurance Program |
CDC |
Centers for Disease Control and Prevention |
NewSTEPs |
Newborn Screening Technical Assistance and Evaluation Program |
CCR |
Consumer Contracted Reagents |
PE |
Perkin Elmer Wallac, INC. |
FIA |
Flow Injection Analysis |
UPLC |
Ultra-high-Performance Liquid Chromatography |
r2 |
Coefficient of determination |
GALC |
Galactocerebrosidase |
QCBP |
QC base pool |